onsdag 3 juni 2015

Innovation and risk taking are the key to tackling antibiotic resistance

Would Alexander Fleming’s haphazard discovery of the penicillium fungus have been approved today by the FDA and EMA? Research to fight antibiotic resistant bacteria is a problematic issue, especially since the pharmaceutical market is heavily regulated. In CapX of June 2nd 2015 I write about Innovation and risk taking are the key to tackling antibiotic resistance.

Läs även andra bloggares åsikter om , , , , , , , ,

Intressant